Skip to main content

Table 3 Multivariate analysis of the five-year Cox proportional hazard model of LRRFS; OS; DMFS; and PFS. The matched pair comparison of clinical characteristics between the radiosensitive group (n = 90) and radioresistant group (n = 90)

From: Prognostic value of phosphorylated Raf kinase inhibitory protein at serine 153 and its predictive effect on the clinical response to radiotherapy in nasopharyngeal carcinoma

Items

Radiosensitive group

Radioresistant group

P

T Stage

T1(cases)

14

11

>0.05

T2(cases)

36

33

T3(cases)

28

32

T4(cases)

12

14

N Stage

N0(cases)

26

23

>0.05

N1(cases)

36

39

N2(cases)

23

20

N3(cases)

5

8

TNM Stage

I(cases)

14

10

>0.05

II(cases)

35

34

III(cases)

29

32

IV(cases)

12

14

WHO Classification

I (cases)

12

14

>0.05

II(cases)

24

28

III(cases)

54

48

Sex

Man(cases)

49

55

>0.05

Female(cases)

41

35

Age

(\( \overline{x}\pm s \))(cases)

44.5 ± 14

49.0 ± 12

>0.05

Preatment Hemoglobin(g/L) (\( \overline{x}\pm s \))

138.5 ± 13.2

135.8 ± 15.5

>0.05

Total irradiation dose of primary nasopharyngeal carcinoma (Gy) (\( \overline{x}\pm s \))

72.5 ± 4.2

72.6 ± 3.8

>0.05

Total irradiation dose of positive neck lymph node (Gy) (\( \overline{x}\pm s \))

62.2 ± 2.3

64.5 ± 4.2

>0.05

Preventive irradiation dose of negative neck lymph node (Gy) (\( \overline{x}\pm s \))

54.2 ± 3.3

53.5 ± 4.3

>0.05